Free shipping on all orders over $ 500

PARP14 inhibitor H10 

Cat. No. M29181

All AbMole products are for research use only, cannot be used for human consumption.

PARP14 inhibitor H10  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

PARP14 inhibitor H10, compound H 10, is a selective inhibitor against PARP14 (IC50=490 nM), over other PARPs (≈24 fold over PARP1). PARP14 inhibitor H10 induces caspase-3/7-mediated cell apoptosis.

Chemical Information
Molecular Weight 557.58
Formula C24H27N7O7S
CAS Number 2084811-68-5
Form Solid
Solubility (25°C) DMSO 62.5 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Bo Peng, et al. Angew Chem Int Ed Engl. Small Molecule Microarray Based Discovery of PARP14 Inhibitors

Related PARP Products
2-Methylquinazolin-4-ol

2-Methylquinazolin-4-ol is a potent competitive poly(ADP-ribose) synthetase inhibitor, with a Ki of 1.1 μM. 2-Methylquinazolin-4-ol mammalian aspartate transcarbamylase (ATCase) inhibitor, with IC50 of 0.20 mM.

DPQ 

DPQ is a potent PARP-1 inhibitor.

OUL232 

OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15.

AZ3391 

AZ3391 is a potent inhibitor of PARP.

PARP1-IN-5 

PARP1-IN-5 is a low toxicity, orally active, potent and selective PARP-1 inhibitor (IC50 =14.7 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: PARP14 inhibitor H10  supplier, PARP, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.